Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-23-000218
Filing Date
2023-02-14
Accepted
2023-02-14 14:15:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13G wavelife13ga1-123122.htm SC 13G/A 69221
  Complete submission text file 0001013594-23-000218.txt   71029
Mailing Address 1700 BROADWAY SUITE 4200 NEW YORK NY 10019
Business Address 1700 BROADWAY SUITE 4200 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

EIN.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Subject) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89180 | Film No.: 23627006
SIC: 2834 Pharmaceutical Preparations